Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.3886
Abstract: First‐line platinum‐based therapy for advanced squamous cell carcinomas of the anal canal (SCCA) implies a risk of substantial side effects, and data on second‐line treatment options are limited. Paclitaxel and Capecitabine are a well‐known regimen… read more here.
Keywords: squamous cell; carcinomas anal; anal canal; based therapy ... See more keywords
Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.6011
Abstract: 6011Background: Pembrolizumab (pembro) is a humanized monoclonal antibody that blocks the programmed death receptor-1 (PD-1) interaction with its ligands (PD-L1, PD-L2). While pembro is approved fo... read more here.
Keywords: chemoradiation crt; advanced squamous; locally advanced; safety pembrolizumab ... See more keywords
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2021-1634
Abstract: Xevinapant is a first-in-class antagonist of inhibitor of apoptosis proteins, which enhances cancer cell sensitivity to chemotherapy and radiotherapy. In a phase II randomized study in patients with unresected locally advanced squamous cell carcinoma of the… read more here.
Keywords: locally advanced; advanced squamous; placebo; phase ... See more keywords
The efficacy of PD-1/PD-L1 inhibitors in advanced squamous-cell lung cancer: a meta-analysis of 3112 patients.
Sign Up to like & getrecommendations! Published in 2019 at "Immunotherapy"
DOI: 10.2217/imt-2019-0101
Abstract: Aim: We performed a meta-analysis to explore the efficacy of immunotherapy for patients with squamous non-small-cell lung cancer (NSCLC). Materials & methods: Randomized clinical trials comparing immunotherapy with chemotherapy for advanced NSCLC patients were included.… read more here.
Keywords: cell lung; 3112 patients; lung cancer; squamous nsclc ... See more keywords
Short-term efficacy and safety of apatinib in advanced squamous cell carcinoma of the lung.
Sign Up to like & getrecommendations! Published in 2017 at "Indian journal of cancer"
DOI: 10.4103/ijc.ijc_379_17
Abstract: OBJECTIVE To evaluate the short-term efficacy and safety of apatinib alone or combined with chemotherapy in the treatment of advanced squamous cell lung cancer. METHODS Forty patients with advanced squamous cell lung carcinoma were enrolled… read more here.
Keywords: term efficacy; cell; squamous cell; short term ... See more keywords
Advanced squamous cell carcinoma with massive cranial invasion: walking around without a forehead.
Sign Up to like & getrecommendations! Published in 2022 at "Dermatology online journal"
DOI: 10.5070/d328257404
Abstract: Squamous cell carcinomas with widespread invasion of the skull, meninges and brain parenchyma are extremely rare. Herein, we present an 86-year-old man with an 18-year history of sunburn who developed a large osteodestructive SCC that… read more here.
Keywords: cell carcinoma; cell; carcinoma massive; squamous cell ... See more keywords